effect of regimenal therapy in primary varicose vein

Efficacy 0f fasd venesection and tila in dawali primary varicose vein a randomised controlled clinical trail - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/0102118

Enrollment

Registered

2026-01-27

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I839- Asymptomatic varicose veins of lower extremities

Interventions

Intervention1: Fasd and Tila aaplication: Patients will undergo venesection on the affected veins after full aseptic precautions and vital monitoring. after that the Tila will be applied over the engo

Eligibility

Inclusion criteria

Inclusion criteria: Patients clinically diagnosed with primary varicose veins Varicosity Mild to Moderate on venous clinical severity score Patients between 30 to 60 years of Age Either gender Willing to sign the informed consent form

Exclusion criteria

Exclusion criteria: Patients having grade II hypertension Pregnant and lactating women Patients who fail to follow up Patients having uncontrolled Diabetes mellitus and other Systemic illness Patients with Hb less than 9.5 Patients having bleeding diathesis, HIV infection, hepatitis B and C infection Patients of deep venous thrombosis Patients having varicose ulcers.

Design outcomes

Primary

Measure	Time frame
Venous Clinical Severity Score (VCSS)Timepoint: 0,7th ,14th,21st days	—

Secondary

Measure	Time frame
SF -12 for quality of life.Timepoint: 0,7th,,14th,21st days	—

Countries

India

Contacts

Public ContactDr Abdul Azeez

National institute of unani medicine

aafaris@gmail.com9072310021

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026